Conflicts of interest: None declared.
Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications
Article first published online: 4 JAN 2011
© 2011 The Authors. International Journal of Stroke © 2011 World Stroke Organization
International Journal of Stroke
Volume 6, Issue 1, pages 42–46, February 2011
How to Cite
Brainin, M., Norrving, B., Sunnerhagen, K. S., Goldstein, L. B., Cramer, S. C., Donnan, G. A., Duncan, P. W., Francisco, G., Good, D., Graham, G., Kissela, B. M., Olver, J., Ward, A., Wissel, J., Zorowitz, R. and on behalf of International PSS Disability Study Group (2011), Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. International Journal of Stroke, 6: 42–46. doi: 10.1111/j.1747-4949.2010.00539.x
- Issue published online: 4 JAN 2011
- Article first published online: 4 JAN 2011
This paper represents the opinion of a group of researchers and clinicians with an established interest in poststroke care and is based on the recognised need for long-term care following stroke, especially in view of the global increase of disability due to stroke. Among the more frequent long-term complications following stroke are spasticity-related disabilities. Although spasticity alone occurs in up to 60% of stroke survivors, disabling spasticity affects only 4–10%. Spasticity further interferes with important functions of daily life when it occurs in association with pain, motor impairment, and overall declines of cognitive and neurological function. It is proposed that the aftermath of stroke be considered a chronic disease requiring a multifactorial and multilevel approach. There are, however, knowledge gaps related to the prediction and recognition of poststroke disability. Interventions to prevent or minimise such disabilities require further development and evaluation. Poststroke spasticity research should focus on reducing disability and be considered as part of a continuum of chronic care requirements and should be recognised as a part of a comprehensive poststroke disease management programme.